DotEndo
Diagnosis of active endometriosis
NAActive
Key Facts
About DotLab
DotLab is a private, US-based diagnostics company founded in 2015 to tackle the chronic under-diagnosis of endometriosis. Its core innovation is the DotEndo test, a first-of-its-kind blood test that analyzes microRNA signatures to identify active disease, potentially reducing the decade-long diagnostic delay. The company is currently in the commercial rollout phase, making the test available to select providers while continuing to validate it through clinical studies like the EMPOWER trial.
View full company profile